| 摘要 |
The present invention relates to pharmaceutical compositions in dry powder form comprising tiotropium and mometasone furoate and/or their pharmaceutically acceptable derivatives as active agents, and capsule and blister forms containing these pharmaceutical compositions so as to be used in treatment of respiratory tract diseases. |
